Bas D. Koster
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Lymphatic System and Diseases
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- T-cell and B-cell Immunology
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 6
- Cutaneous Melanoma Detection and Management 5
-
- Immunotherapy and Immune Responses 7
- Co-authors
- Tanja D. de Gruijl (13 shared papers)Alfons J.M. van den Eertwegh (10 shared papers)Ekaterina S. Jordanova (2 shared papers)Anne Marijne Heeren (3 shared papers)Rik J. Scheper (6 shared papers)Mari F.C.M. van den Hout (6 shared papers)Berbel J.R. Sluijter (6 shared papers)Barbara G. Molenkamp (6 shared papers)
- Journals
- Cancer Immunology Research (3 papers)Cancer Immunology Immunotherapy (2 papers)Blood (1 paper)Current Opinion in Oncology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Bas D. Koster
12 papers receiving 440 citations
Peers
Comparison fields: 5 of 34
- Oncology 239
- Immunology 201
- Obstetrics and Gynecology 16
- Biomaterials 15
- Epidemiology 37
Countries citing papers authored by Bas D. Koster
This map shows the geographic impact of Bas D. Koster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas D. Koster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas D. Koster more than expected).
Fields of papers citing papers by Bas D. Koster
This network shows the impact of papers produced by Bas D. Koster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas D. Koster. The network helps show where Bas D. Koster may publish in the future.
Co-authors
The 25 scholars most cited alongside Bas D. Koster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 102 | |
| 2 | 2019 | 60 | |
| 3 | 2017 | 59 | |
| 4 | 2015 | 57 | |
| 5 | 2017 | 44 | |
| 6 | 2022 | 42 | |
| 7 | 2015 | 27 | |
| 8 | 2021 | 22 | |
| 9 | 2019 | 19 | |
| 10 | 2019 | 8 | |
| 11 | 2012 | 3 | |
| 12 | 2014 | 1 | |
| 13 | 2025 | 0 | |
| 14 | 2025 | 0 | |
| 15 | 2026 | 0 |
About Bas D. Koster
Bas D. Koster is a scholar working on Oncology, Immunology, Hematology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 15 papers that have together received 444 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cutaneous Melanoma Detection and Management (5 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Oncology (239 citations), Immunology (201 citations), Obstetrics and Gynecology (16 citations), Biomaterials (15 citations) and Epidemiology (37 citations). Bas D. Koster has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Tanja D. de Gruijl, Alfons J.M. van den Eertwegh, Ekaterina S. Jordanova, Anne Marijne Heeren, Rik J. Scheper, Mari F.C.M. van den Hout, Berbel J.R. Sluijter, Barbara G. Molenkamp, Paul A.M. van Leeuwen and Dafni Chondronasiou. Their work appears in journals such as Cancer Immunology Research, Cancer Immunology Immunotherapy, Blood, Current Opinion in Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.